Identification of the immunological profile in rejection-free heart transplantation.

[1]  M. Ansari,et al.  A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants , 2018, Scientific Reports.

[2]  Giovanna Lombardi,et al.  Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells , 2018, Front. Immunol..

[3]  K. Wood,et al.  Regulatory T cells for tolerance. , 2017, Human immunology.

[4]  Jeong-Hee Yang,et al.  Therapeutic application of T regulatory cells in composite tissue allotransplantation , 2017, Journal of Translational Medicine.

[5]  A. Khosravi,et al.  The effects of prolonged azathioprine administration on blood cells, lymphocytes and immunoglobulins of Iranian mixed-breed dogs , 2017 .

[6]  B. Sawitzki,et al.  Immune monitoring as prerequisite for transplantation tolerance trials , 2017, Clinical and experimental immunology.

[7]  R. Lechler,et al.  Regulatory T cells: tolerance induction in solid organ transplantation , 2017, Clinical and experimental immunology.

[8]  C. Spada,et al.  Regulatory T Lymphocytes (Treg): Modulation and Clinical Application , 2017 .

[9]  L. Riella,et al.  Treg‐Centric View of Immunosuppressive Drugs in Transplantation: A Balancing Act , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  Q. Tang,et al.  Impact of Immune-Modulatory Drugs on Regulatory T Cell , 2016, Transplantation.

[11]  S. Todo,et al.  A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation , 2016, Hepatology.

[12]  F. Mohr,et al.  Dendritic Cells and Their Role in Cardiovascular Diseases: A View on Human Studies , 2016, Journal of immunology research.

[13]  Jianghua Chen,et al.  mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis , 2015, BMC Nephrology.

[14]  E. Bonifacio,et al.  Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease. , 2015, Cytotherapy.

[15]  F. Mohr,et al.  Role of dendritic cells in the context of acute cellular rejection: Comparison between Tacrolimus- or Cyclosporine A-treated heart transplanted recipients. , 2014, Cytometry. Part B, Clinical cytometry.

[16]  F. Mohr,et al.  Immunological monitoring of extracorporeal photopheresis after heart transplantation , 2014, Clinical and experimental immunology.

[17]  J. Yang,et al.  Third‐party Tolerogenic Dendritic Cells Reduce Allo‐reactivity In vitro and Ameliorate the Severity of Acute graft‐Versus‐host Disease in Allo‐bone Marrow Transplantation , 2013, Scandinavian journal of immunology.

[18]  J. Dernedde,et al.  L-selectin--a dynamic regulator of leukocyte migration. , 2012, European journal of cell biology.

[19]  B. Falini,et al.  Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.

[20]  J. Wagner,et al.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.

[21]  X. Zheng,et al.  T regulatory cells and transplantation tolerance. , 2010, Transplantation reviews.

[22]  M. Toribio,et al.  Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. , 2010, Blood.

[23]  T. Kawai,et al.  Induction of tolerance in clinical kidney transplantation , 2010, Clinical transplantation.

[24]  P. Tam,et al.  Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? , 2010, Transplantation reviews.

[25]  Yong‐jun Liu,et al.  Thymic Stromal Lymphopoietin-Activated Plasmacytoid Dendritic Cells Induce the Generation of FOXP3+ Regulatory T Cells in Human Thymus , 2010, The Journal of Immunology.

[26]  Karina Pino-Lagos,et al.  Cyclosporin A-treated dendritic cells may affect the outcome of organ transplantation by decreasing CD4+CD25+ regulatory T cell proliferation. , 2010, Biological research.

[27]  Sheng-fu Li,et al.  Peripheral blood T Regulatory cell counts may not predict transplant rejection , 2010, BMC Immunology.

[28]  J. Myśliwska,et al.  First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. , 2009, Clinical immunology.

[29]  Shimon Sakaguchi,et al.  Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation , 2008, Proceedings of the National Academy of Sciences.

[30]  A. Thomson,et al.  Tolerogenic dendritic cells and the quest for transplant tolerance , 2007, Nature Reviews Immunology.

[31]  R. Lechler,et al.  In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. , 2007, Blood.

[32]  R. Blaheta,et al.  Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil , 2003, Spinal Cord.

[33]  G. Mazariegos,et al.  Dendritic Cell Subset Ratio in Peripheral Blood Correlates with Successful Withdrawal of Immunosuppression in Liver Transplant Patients , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  Tomoki Ito,et al.  Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets , 2003, Immunology.

[35]  J. Gummert,et al.  Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. , 2001, Journal of immunological methods.

[36]  Ethan M. Shevach,et al.  Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific , 2000, The Journal of Immunology.

[37]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.